Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7

American Journal of Pathology

Volumn 173, Issue 5, 2008, Pages 1428-1439

  Toledo, Carla Calderon ^a   Rogers, Trisha Jayne ^a,b   Svensson, Majlis ^b   Tati, Ramesh ^a   Fischer, Hans ^b   Svanborg, Catharina ^b   Karpman, Diana ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CREATININE; FIBRINOGEN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TRIF; SHIGA TOXIN; STREPTOMYCIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; C57BL 6 MOUSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DESQUAMATION; DISEASE SEVERITY; EDEMA; ENTERITIS; ENTEROBACTER INFECTION; ERYTHROCYTE COUNT; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; GLOMERULUS CAPILLARY; HEMOLYSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INNATE IMMUNITY; INOCULATION; INTESTINE INJURY; KIDNEY TUBULE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RETICULOCYTOSIS; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; THROMBOCYTOPENIA; WILD TYPE;

EID: 55349142883     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.071218     Document Type: Article

References (40)

1. Griffin PM: Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. Infections of the gastrointestinal tract. Edited by MJ Blaser, PD Smith, JI Ravdin, HB Greenberg, RL Guerrant. Raven Press, New York. 1995, 739-761
2. Arbus GS: Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. Kidney Int 1997, 58:S91-S96
3. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H: The association between idiopathic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985, 151:775-782
4. Kaper JB. Enterohemorrhagic Escherichia coli. Curr Opin Microbiol 1998, 1:103-108
5. Paton JC, Paton AW: Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998, 11:450-479
6. Thorpe CM, Hurley BP, Acheson DW: Shiga toxin interactions with the intestinal epithelium. Methods Mol Med 2003, 73:263-273
7. van Setten PA, Monnens LA, Verstraten RG, van den Heuvel LP, van Hinsbergh VW: Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 1996, 88:174-183
8. Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D: Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006, 108:167-176
9. Lindberg AA, Brown JE, Strömberg N, Westling-Ryd M, Schultz JE, Karlsson KA: Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 1987, 262:1779-1785
10. Boyd B, Lingwood C: Verotoxin receptor glycolipid in human renal tissue. Nephron 1989, 51:207-210
11. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C: The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997, 175:611-620
12. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD: Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990, 58:3959-3965
13. Lindgren S, Melton A, O'Brien A: Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 1993, 61:3832-3842
14. Proulx F, Seidman EG, Karpman D: Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 2001, 50:163-171
15. Keepers TR, Psotka MA, Gross LK, Obrig TG A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 2006, 17:3404-3414
16. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14
17. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511
18. Akira S, Yamamoto M, Takeda K: Role of adapters in Toll-like receptor signalling. Biochem Soc Trans 2003, 31:637-642
19. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B: Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003, 424:743-748
20. Kawai T, Takeuchi O, Fujita T, Inoue J, Mühlradt PF, Sato S, Hoshino K, Akira S: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes. J Immunol 2001, 167:5887-5894
21. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150
22. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162:3749-3752
23. O'Brien AD, Melton AR, Schmitt CK, McKee ML, Batts ML, Griffin DE: Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol 1993, 31:2799-2801
24. Rogers TJ, Paton JC, Wang H, Talbot UM, Paton AW: Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113: H21. Infect Immun 2006, 74:1962-1966
25. Karmali MA, Petric M, Lim C, Cheung R, Arbus GS: Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol 1985, 22:614-619
26. Wadolkowski EA, Burris JA, O'Brien AD: Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1990, 58:2438-2445
27. Hogan K, Maeda N, Kluckman K, Lord S: Synthesis of a mouse model of the dysfibrinogen Vlissingen/Frankfurt IV. Ann NY Acad Sci 2001, 936:117-121
28. Miyamoto Y, Iimura M, Kaper JB, Torres AG, Kagnoff MF: Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol 2006, 8:869-879
29. Miyake K: Endotoxin recognition molecules. Toll-like receptor 4-MD-2 Semin Immunol 2004, 16:11-16
30. Funda DP, Tucková L, Farré MA, Iwase T, Moro I, Tlaskalová-Hogenová H: CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun 2001, 69:3772-3781
31. Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG: MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 2007, 204:1891-1900
32. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, Vallance BA: MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 2008, 10:618-631
33. Lebeis SL, Bommarius B, Parkos CA, Sherman MA, Kalman D: TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 2007, 179:566-577
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241
35. Strober W: Epithelial cells pay a Toll for protection. Nat Med 2004, 10:898-900
36. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088
37. Eaton KA, Friedman DI, Francis GJ, Tyler JS, Young VB, Haeger J, Abu-Ali G, Whittam TS: The pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ free mice. Infect Immun 2008, 76:3054-3063
38. Taylor FB Jr., Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL: Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 1999, 154:1285-1299
39. Hertzke DM, Cowan LA, Schoning P, Fenwick BW: Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 1995, 32:451-459
40. Karpman D, Papadopoulou D, Nilsson K, Sjogren AC, Mikaelsson C, Lethagen S: Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 2001, 97:3100-3108